The modern paradigm of pathophysiology, prevention and treatment of heart failure in type 2 diabetes mellitus

Prevention and choice  of therapeutic strategies in patient,s  with type 2 diabetes (T2D) and heart failure (HF) is an urgent problem. This review presents a modern concept for HF development  from early  stages of T2D. Glucose-lowering  and cardiac  medications  for the  prevention  and  treatment...

Full description

Bibliographic Details
Main Authors: Zh. D. Kobalava, V. V. Medovchshikov, N. B. Yeshniyazov, E. R. Khasanova
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2019-11-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/3581
_version_ 1797856772101242880
author Zh. D. Kobalava
V. V. Medovchshikov
N. B. Yeshniyazov
E. R. Khasanova
author_facet Zh. D. Kobalava
V. V. Medovchshikov
N. B. Yeshniyazov
E. R. Khasanova
author_sort Zh. D. Kobalava
collection DOAJ
description Prevention and choice  of therapeutic strategies in patient,s  with type 2 diabetes (T2D) and heart failure (HF) is an urgent problem. This review presents a modern concept for HF development  from early  stages of T2D. Glucose-lowering  and cardiac  medications  for the  prevention  and  treatment of HF depending   on  its phenotypes were considered.
first_indexed 2024-04-09T20:45:59Z
format Article
id doaj.art-bd265992d55c487299c6d6e34d3cde83
institution Directory Open Access Journal
issn 1560-4071
2618-7620
language Russian
last_indexed 2024-04-09T20:45:59Z
publishDate 2019-11-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj.art-bd265992d55c487299c6d6e34d3cde832023-03-29T21:23:34Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202019-11-010119811110.15829/1560-4071-2019-11-98-1112784The modern paradigm of pathophysiology, prevention and treatment of heart failure in type 2 diabetes mellitusZh. D. Kobalava0V. V. Medovchshikov1N. B. Yeshniyazov2E. R. Khasanova3Peoples' Friendship University of Russia (RUDN University); Vinogradov City HospitalPeoples' Friendship University of Russia (RUDN University)Peoples' Friendship University of Russia (RUDN University)Peoples' Friendship University of Russia (RUDN University)Prevention and choice  of therapeutic strategies in patient,s  with type 2 diabetes (T2D) and heart failure (HF) is an urgent problem. This review presents a modern concept for HF development  from early  stages of T2D. Glucose-lowering  and cardiac  medications  for the  prevention  and  treatment of HF depending   on  its phenotypes were considered.https://russjcardiol.elpub.ru/jour/article/view/3581diabetesheart failuresubclinical myocardial dysfunctiondiabetic cardiomyopathydiabetic nephropathypreserved ejection fractionpathophysiologysglt2 inhibitors
spellingShingle Zh. D. Kobalava
V. V. Medovchshikov
N. B. Yeshniyazov
E. R. Khasanova
The modern paradigm of pathophysiology, prevention and treatment of heart failure in type 2 diabetes mellitus
Российский кардиологический журнал
diabetes
heart failure
subclinical myocardial dysfunction
diabetic cardiomyopathy
diabetic nephropathy
preserved ejection fraction
pathophysiology
sglt2 inhibitors
title The modern paradigm of pathophysiology, prevention and treatment of heart failure in type 2 diabetes mellitus
title_full The modern paradigm of pathophysiology, prevention and treatment of heart failure in type 2 diabetes mellitus
title_fullStr The modern paradigm of pathophysiology, prevention and treatment of heart failure in type 2 diabetes mellitus
title_full_unstemmed The modern paradigm of pathophysiology, prevention and treatment of heart failure in type 2 diabetes mellitus
title_short The modern paradigm of pathophysiology, prevention and treatment of heart failure in type 2 diabetes mellitus
title_sort modern paradigm of pathophysiology prevention and treatment of heart failure in type 2 diabetes mellitus
topic diabetes
heart failure
subclinical myocardial dysfunction
diabetic cardiomyopathy
diabetic nephropathy
preserved ejection fraction
pathophysiology
sglt2 inhibitors
url https://russjcardiol.elpub.ru/jour/article/view/3581
work_keys_str_mv AT zhdkobalava themodernparadigmofpathophysiologypreventionandtreatmentofheartfailureintype2diabetesmellitus
AT vvmedovchshikov themodernparadigmofpathophysiologypreventionandtreatmentofheartfailureintype2diabetesmellitus
AT nbyeshniyazov themodernparadigmofpathophysiologypreventionandtreatmentofheartfailureintype2diabetesmellitus
AT erkhasanova themodernparadigmofpathophysiologypreventionandtreatmentofheartfailureintype2diabetesmellitus
AT zhdkobalava modernparadigmofpathophysiologypreventionandtreatmentofheartfailureintype2diabetesmellitus
AT vvmedovchshikov modernparadigmofpathophysiologypreventionandtreatmentofheartfailureintype2diabetesmellitus
AT nbyeshniyazov modernparadigmofpathophysiologypreventionandtreatmentofheartfailureintype2diabetesmellitus
AT erkhasanova modernparadigmofpathophysiologypreventionandtreatmentofheartfailureintype2diabetesmellitus